IL-12 R beta 1 in IL-12/IL-23 Drug Development: Where the Receptor Fits in Three Steps
From target-engagement assays to receptor-occupancy studies for IL-23 blockers, IL-12Rβ1 reagents anchor the autoantibody development chain. This article traces it.
- Recent Advances
- Product Information
Recent Advances
Abstract: From target-engagement assays to receptor-occupancy studies for IL-23 blockers, IL-12Rβ1 reagents anchor the autoantibody development chain. This article traces it.
Keywords: IL-12R beta 1, IL-23 inhibitor, receptor occupancy, target engagement, autoimmune, UA010956
Note: The full article is published in Chinese. Please refer to the Chinese version for complete experimental details, figures and product references. For product inquiries, visit www.ua-bio.com.
Product Information






